Bistability of Beta- Cell Mass in Type 2 Diabetes

Size: px
Start display at page:

Download "Bistability of Beta- Cell Mass in Type 2 Diabetes"

Transcription

1 Bistability of Beta- Cell Mass in Type 2 Diabetes Arthur Sherman and Joon Ha Laboratory of Biological Modeling NIDDK, NaEonal InsEtutes of Health Bethesda, MD USA 1

2 What is Insulin? A key hormone to regulate fuel use Cells can use carbohydrate (glucose), fat or protein Secreted by pancreaec beta cells Allows muscles to consume glucose When faseng, muscles use fat When fed, muscles use glucose, fat stored in fat cells 2

3 Insulin is Secreted by b- cells in Islets in the Pancreas 3

4 What is Diabetes? Absolute or relaeve lack of insulin Absolute: Type 1 diabetes loss of beta cells RelaEve: Type 2 diabetes - insulin resistance; associated with Obesity Age Lack of exercise Inability to consume glucose results in hyperglycemia Organ damage and premature death 4

5 What We Know Obesity causes insulin resistance If beta cells compensate, no diabetes 5

6 What We Don t Know How do beta cells compensate? FuncEon (secreeon/cell)? Mass (number of cells)? What is the signal for compensaeon? Glucose? Insulin? 6

7 The Natural History of Diabetes: Starling s law of the pancreas Humans DeFronzo, Diabetes 37: (Lilly Lecture) 7

8 What We Want to Simulate: ZDF Rat Failure CompensaEon LF-fZDF ( ) HF-fZDF ( ) Topp BG et al. Am J Physiol Endocrinol Metab 2007;293:E1730-E1735 8

9 The CriEcal Experiment: Islet TransplantaEon Mass homeostasis is regulated by workload, not glucose Dadon et al, Diabetes, Obesity and Metabolism 14 Suppl 3:101-8,

10 Hypothesis: Mass homeostasis is regulated by workload (secreeon per cell) SecreEon > Metabolism: Mass increases SecreEon (per cell) Metabolic Rate Metabolism > SecreEon: Mass decreases 10

11 SecreEon is SEmulated by Glucose Metabolism Glucokinase KATP 11

12 The Model (1) Adapted from Bergman- Cobelli Minimal Model dg dt = R 0 (E G0 + S I I)G di dt = βσ ISR(M ) ki M body Conclusions: If S I decreases, normal faseng G can be maintained by proporeonally increasing I and b It is difficult to disentangle b and s. 12

13 The Model (2) Fast Slow dg dt = R 0 (E G0 + S I I)G di dt = βσ ISR(M ) ki M body dβ dt = (P A)β τ β Topp Finegood, J. Theor. Biol. 206:

14 Proposed Hierarchy of b- Cell Response Post- prandial G rise: Travel up the dose response curve. Persistent high G (days rodent, weeks - human): Shih the dose response curve to the leh (higher Ca; g) Increase efficacy of Ca (amplificaeon factor; s). Persistent high workload: Proliferate. 14

15 The Model (3) Fast Intermediate dg dt = R 0 (E G0 + S I I)G di dt = βσ ISR(M;γ) ki M body dγ dt = γ (G) γ τ γ Slow dβ dt = (P A)β τ β 15

16 The Auxiliary FuncEons γ s 16

17 CompensaEon for Insulin Resistance S I stepped down from 0.8 to 0.4 Note: Increase in G is ~10%, increase in ISR ~100%. Increase in g Increase in b GDR 17

18 How CompensaEon Happens HomeostaEc control of workload leads naturally to homeostaec control of G via increased mass Workload is a more sensieve indicator of demand for insulin than G Can also compensate by increased funceon (s) 18

19 Case Study: ZDF Rats LF-fZDF ( ) HF-fZDF ( ) Insulin peaks before mass: FuncEon (s) must decline Topp BG et al. Am J Physiol Endocrinol Metab 2007;293:E1730-E

20 The Model (4) β τ γ τ β β σ σ σ σ τ γ γ γ γ βσ ) ( ), ( ) ( ) ; ( ) ( 0 0 A P dt d ISR M dt d G dt d ki M ISR M dt di G I S E R dt dg body I G = = = = + = 20 Fast Slow Intermediate

21 Proposed Mechanism for FuncEon Defect ISR M 21

22 Hypothesis: The only difference between LFD and HFD rats is rate and extent of fall in S I 22

23 SimulaEons of ZDF Rats Note: Insulin peaks before mass 23

24 How Failure Happens Increased workload increases mass If mass fails to increase rapidly enough, funceon declines Decline of funceon leads to beta- cell death To maintain normoglycemia, need b to increase as fast as S I falls 24

25 Starling s law of the pancreas Humans Rats (SimulaEon) 25

26 Recall: The Fast G- I Subsystem Adapted from Bergman- Cobelli Minimal Model dg dt = R 0 (E G0 + S I I)G di dt = βσ ISR(M ) ki M body 26

27 Curves of constant G Progressive ReducOon of S I Slow reduceon of S I : b increases, G mildly elevated (constant disposieon index) Rapid reduceon of S I : b Eventually decreases, G rises (decreased disposieon index)

28 Dynamics of the Disposition Index in ZDF Rats Falling off the DI curve corresponds to the Starling peak Topp B G et al. Am J Physiol Endocrinol Metab 2007;293:E1730-E by American Physiological Society

29 Reversing Diabetes: Look Ahead Trial Goal: Lose 7% of body weight through moderate calorie reduceon and exercise Only about 10% experienced remission first year, many relapsed over the next few years In contrast, a similar interveneon in pre- diabetes reduced conversion to diabetes 56% Gregg et al, JAMA 308:

30 Intensive Lifestyle IntervenEon: Early and Rapid Succeed, Late Fails 30

31 Bariatric Surgery hmp:// 31

32 Rapid Reversal of DM by Bariatric Surgery Increase S i, reduce R 0, increase s 32

33 P 0.04 A G G P, A P A, AMmax=0.55 A, AMmax=0.3 P-A G G

34 The Central Principle ISR- based homeostasis plus a threshold explains everything 34

35 Lifestyle IntervenEon: Must be Early and Rapid 35

36 Rapid Reversal of DM by Bariatric Surgery 36

37 The Heart of the Model: Threshold and Bistability [300] Disease G mg/dl [150] [125] Acute caloric restriceon [100] Health b- cell Mass Defect

38 The Full Slow Dynamics 38

39 Important: S i can t change b, G steady states but can shih the trajectory across thresholds 39

40 The Heart of the Model: Threshold and Bistability [300] Disease G mg/dl [150] [125] Acute caloric restriceon [100] Health b- cell Mass Defect

41 Is There Evidence for a Threshold? 41

42 Longitudinal Two-Hour Glucose Measurements in 55 Pima Indians Mason et al., Diabetes 2007;56: Copyright 2011 American Diabetes Association, Inc.

43 Is There Evidence for Bistability? 43

44 Partial Pancreatectomy Results in Bimodal Glycemia Experiment, Laybum et al, JBC, 2003 SimulaEon 60 Percentage of Diabetes 30 Model tells us: Bimodality results from Bistability 70% Ptx 90% Ptx Model PredicEon 44

45 Monostable Model No rapid reversal of diabetes 45

46 Conclusions No one cause, but dynamic balance of mass, funceon and insulin resistance Workload, not G per se, drives compensaeon to insulin resistance Diabetes results when resistance worsens faster than secreeon rises Model is bistable with a threshold: Below threshold, mass increases; above, mass decreases Peak in Starling s law of the pancreas corresponds to crossing the threshold Explains why preveneon is easier than cure Explains why bariatric surgery works: Improves insulin sensievity rapidly 46

47 47

48 Don t Pop the Champaign Cork Yet Model reinforces emphasis on preveneon but we don t have drugs safe enough to give to people who are not yet sick. Clinical researchers want to know what molecules to target model can t tell them that. Concern that it doesn t apply to humans. 48

49 [300] Gordon Weir, Susan Bonner- Weir, Five Stages of b- Cell DysfuncEon, Diabetes 53, Supp. 3, Dec Severe DecompensaOon irreversible G mg/dl [150] [125] 4 Stable DecompensaOon frank diabetes 3 Transient DecompensaOon G rises rapidly [100] 1 CompensaOon normal G 2 Stable AdaptaOon reduced mass and funcoon, G starts to rise b- cell Defect 49

50 Five Stages of Progression of Diabetes Weir G C, and Bonner-Weir S Diabetes 2004;53:S16-S21 Copyright 2011 American Diabetes Association, Inc. 50

Numerical investigation of phase transition in a cellular network and disease onset

Numerical investigation of phase transition in a cellular network and disease onset Numerical investigation of phase transition in a cellular network and disease onset Xujing Wang, Associate Professor Dept of Physics xujingw@uab.edu 934-8186 The question: Is (chronic) disease onset a

More information

OVERVIEW OF PEDIATRIC DIABETES Alan B. Cortez, M.D. Pediatric Endocrinology Chief, Department of Pediatrics Kaiser-Permanente, Orange County

OVERVIEW OF PEDIATRIC DIABETES Alan B. Cortez, M.D. Pediatric Endocrinology Chief, Department of Pediatrics Kaiser-Permanente, Orange County OVERVIEW OF PEDIATRIC DIABETES 2011 Alan B. Cortez, M.D. Pediatric Endocrinology Chief, Department of Pediatrics Kaiser-Permanente, Orange County Outline of Pediatric Diabetes Presentation Types of Pediatric

More information

What systems are involved in homeostatic regulation (give an example)?

What systems are involved in homeostatic regulation (give an example)? 1 UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY GLUCOSE HOMEOSTASIS (Diabetes Mellitus Part 1): An Overview

More information

INSULIN IN THE OBESE PATIENT JACQUELINE THOMPSON RN, MAS, CDE SYSTEM DIRECTOR, DIABETES SERVICE LINE SHARP HEALTHCARE

INSULIN IN THE OBESE PATIENT JACQUELINE THOMPSON RN, MAS, CDE SYSTEM DIRECTOR, DIABETES SERVICE LINE SHARP HEALTHCARE INSULIN IN THE OBESE PATIENT JACQUELINE THOMPSON RN, MAS, CDE SYSTEM DIRECTOR, DIABETES SERVICE LINE SHARP HEALTHCARE OBJECTIVES DESCRIBE INSULIN, INCLUDING WHERE IT COMES FROM AND WHAT IT DOES STATE THAT

More information

Hormones and Homeostasis

Hormones and Homeostasis Hormones and Homeostasis The endocrine system is a system of organs that releases chemical message molecules, called hormones, into the blood. Unlike the nervous system whose action helps the body react

More information

Chief of Endocrinology East Orange General Hospital

Chief of Endocrinology East Orange General Hospital Targeting the Incretins System: Can it Improve Our Ability to Treat Type 2 Diabetes? Darshi Sunderam, MD Darshi Sunderam, MD Chief of Endocrinology East Orange General Hospital Age-adjusted Percentage

More information

Obesity Management in Patients with Diabetes Jamy D. Ard, MD Sunday, February 11, :15 a.m. 11:00 a.m.

Obesity Management in Patients with Diabetes Jamy D. Ard, MD Sunday, February 11, :15 a.m. 11:00 a.m. Obesity Management in Patients with Diabetes Jamy D. Ard, MD Sunday, February 11, 2018 10:15 a.m. 11:00 a.m. Type 2 diabetes mellitus (T2DM) is closely associated with obesity, primarily through the link

More information

New and Emerging Therapies for Type 2 DM

New and Emerging Therapies for Type 2 DM Dale Clayton MHSc, MD, FRCPC Dalhousie University/Capital Health April 28, 2011 New and Emerging Therapies for Type 2 DM The science of today, is the technology of tomorrow. Edward Teller American Physicist

More information

Hormonal Regulations Of Glucose Metabolism & DM

Hormonal Regulations Of Glucose Metabolism & DM Hormonal Regulations Of Glucose Metabolism & DM What Hormones Regulate Metabolism? What Hormones Regulate Metabolism? Insulin Glucagon Thyroid hormones Cortisol Epinephrine Most regulation occurs in order

More information

AN ORDINARY DIFFERENTIAL EQUATION MODEL OF DIABETIC POPULATION IN NEW DELHI

AN ORDINARY DIFFERENTIAL EQUATION MODEL OF DIABETIC POPULATION IN NEW DELHI Indian Journal of Mathematics and Mathematical Sciences Vol. 7, No. 1, (June 2011) : 45-50 AN ORDINARY DIFFERENTIAL EQUATION MODEL OF DIABETIC POPULATION IN NEW DELHI Sandhya, Deepak Kumar & Prerna Pandit

More information

UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY

UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY 1 UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY GLUCOSE HOMEOSTASIS An Overview WHAT IS HOMEOSTASIS? Homeostasis

More information

MODELING GLUCOSE-INSULIN METABOLIC SYSTEM AND INSULIN SECRETORY ULTRADIAN OSCILLATIONS WITH EXPLICIT TIME DELAYS. Yang Kuang

MODELING GLUCOSE-INSULIN METABOLIC SYSTEM AND INSULIN SECRETORY ULTRADIAN OSCILLATIONS WITH EXPLICIT TIME DELAYS. Yang Kuang MODELING GLUCOSE-INSULIN METABOLIC SYSTEM AND INSULIN SECRETORY ULTRADIAN OSCILLATIONS WITH EXPLICIT TIME DELAYS Yang Kuang (joint work with Jiaxu Li and Clinton C. Mason) Department of Mathematics and

More information

Type 2 Diabetes in Adolescents

Type 2 Diabetes in Adolescents Type 2 Diabetes in Adolescents Disclosures Paid consultant, Eli Lilly, Inc, Pediatric Type 2 Diabetes Clinical Trials Outline The burden of diabetes Treatment and Prevention Youth Diabetes Prevention Clinic

More information

Introduction ORIGINAL RESEARCH. Bilal A. Omar 1, Giovanni Pacini 2 & Bo Ahren 1. Abstract

Introduction ORIGINAL RESEARCH. Bilal A. Omar 1, Giovanni Pacini 2 & Bo Ahren 1. Abstract ORIGINAL RESEARCH Physiological Reports ISSN 2051-817X Impact of glucose dosing regimens on modeling of glucose tolerance and b-cell function by intravenous glucose tolerance test in diet-induced obese

More information

BPA exposure during pregnancy: risk for gestational diabetes and diabetes following pregnancy

BPA exposure during pregnancy: risk for gestational diabetes and diabetes following pregnancy BPA exposure during pregnancy: risk for gestational diabetes and diabetes following pregnancy Paloma Alonso-Magdalena Applied Biology Department and CIBERDEM, Miguel Hernández University, Elche, Spain

More information

Week 3, Lecture 5a. Pathophysiology of Diabetes. Simin Liu, MD, ScD

Week 3, Lecture 5a. Pathophysiology of Diabetes. Simin Liu, MD, ScD Week 3, Lecture 5a Pathophysiology of Diabetes Simin Liu, MD, ScD General Model of Peptide Hormone Action Hormone Plasma Membrane Activated Nucleus Cellular Trafficking Enzymes Inhibited Receptor Effector

More information

type 2 diabetes is a surgical disease

type 2 diabetes is a surgical disease M. Lannoo, MD, University Hospitals Leuven Walter Pories claimed in 1992 type 2 diabetes is a surgical disease Buchwald et al. conducted a large meta-analysis THE FIRST OBSERVATIONS W. Pories 500 patients

More information

New Paradigms of Type 2 Diabetes. From:

New Paradigms of Type 2 Diabetes. From: New Paradigms of Type 2 Diabetes From: www.nusi.org Presenter Disclosure Presenters Jason Fung Relationships with commercial interests: Grants/Research Support: None Grants/Speakers Bureau/Honoraria: Consulting

More information

Objectives 10/11/2013. Diabetes- The Real Cost of Sugar. Diabetes 101: What is Diabetes. By Ruth Nekonchuk RD CDE LMNT

Objectives 10/11/2013. Diabetes- The Real Cost of Sugar. Diabetes 101: What is Diabetes. By Ruth Nekonchuk RD CDE LMNT Diabetes- The Real Cost of Sugar By Ruth Nekonchuk RD CDE LMNT Objectives To explain diabetes To explain the risks of diabetes To enumerate the cost of diabetes to our country To enumerate the cost of

More information

UMBC REU Site: Computational Simulations of Pancreatic Beta Cells

UMBC REU Site: Computational Simulations of Pancreatic Beta Cells UMBC REU Site: Computational Simulations of Pancreatic Beta Cells Sidafa Conde 1, Teresa Lebair 2, Christopher Raastad 3, Virginia Smith 4 Kyle Stern, 5 David Trott 5 Dr. Matthias Gobbert 5, Dr. Bradford

More information

Therapeutic strategy to reduce Glucagon secretion

Therapeutic strategy to reduce Glucagon secretion Clinical focus on glucagon: α-cell as a companion of β-cell Therapeutic strategy to reduce Glucagon secretion Sunghwan Suh Dong-A University Conflict of interest disclosure None Committee of Scientific

More information

Alternative insulin delivery systems: how demanding should the patient be?

Alternative insulin delivery systems: how demanding should the patient be? Diabetologia (1997) 4: S97 S11 Springer-Verlag 1997 Alternative insulin delivery systems: how demanding should the patient be? K.S. Polonsky, M. M. Byrne, J. Sturis Department of Medicine, The University

More information

Why do we care? 20.8 million people. 70% of people with diabetes will die of cardiovascular disease. What is Diabetes?

Why do we care? 20.8 million people. 70% of people with diabetes will die of cardiovascular disease. What is Diabetes? What is Diabetes? Diabetes 101 Ginny Burns RN MEd CDE Diabetes mellitus is a group of diseases characterized by high levels of blood glucose resulting from defects in insulin production, insulin action

More information

Effect of macronutrients and mixed meals on incretin hormone secretion and islet cell function

Effect of macronutrients and mixed meals on incretin hormone secretion and islet cell function Effect of macronutrients and mixed meals on incretin hormone secretion and islet cell function Background. Following meal ingestion, several hormones are released from the gastrointestinal tract. Some

More information

What is Metabolic About Metabolic Surgery? The New ADA Recommendations

What is Metabolic About Metabolic Surgery? The New ADA Recommendations What is Metabolic About Metabolic Surgery? The New ADA Recommendations Obesity Symposium September 16, 2017 Timothy Howland, MD Lourdes Endocrinology Bariatric from the Greek root bar- ("weight" as in

More information

Monthly WellPATH Spotlight November 2016: Diabetes

Monthly WellPATH Spotlight November 2016: Diabetes Monthly WellPATH Spotlight November 2016: Diabetes DIABETES RISK FACTORS & SELF CARE TIPS Diabetes is a condition in which the body does not produce enough insulin or does not use the insulin produced

More information

Figure legends Supplemental Fig.1. Glucose-induced insulin secretion and insulin content of islets. Supplemental Fig. 2.

Figure legends Supplemental Fig.1. Glucose-induced insulin secretion and insulin content of islets. Supplemental Fig. 2. Figure legends Supplemental Fig.. Glucose-induced insulin secretion and insulin content of islets. Insulin secretory responses to.,., and. mm glucose (A) (n = 7-), and the insulin content in the islets

More information

Control of Glucose Metabolism

Control of Glucose Metabolism Glucose Metabolism Control of Glucose Metabolism The pancreas is both an exocrine and endocrine gland. It secretes digestive enzymes into the duodenum (exocrine) and 3 specific hormones into the bloodstream

More information

Mathematical Modeling of Diabetes

Mathematical Modeling of Diabetes Mathematical Modeling of Diabetes Dr. Shyam Kamal Department of Systems Design and Informatics Kyushu Institute of Technology Japan kamal@ces.kyutech.ac.jp 20 May 2016 Overview Role of Glucose Homeostasis

More information

Am I at Risk for Type 2 Diabetes?

Am I at Risk for Type 2 Diabetes? NATIONAL DIABETES INFORMATION CLEARINGHOUSE Am I at Risk for Type 2 Diabetes? Taking Steps to Lower Your Risk of Getting Diabetes U.S. Department of Health and Human Services National Institutes of Health

More information

LESSON 3.2 WORKBOOK. What is fast and slow metabolism?

LESSON 3.2 WORKBOOK. What is fast and slow metabolism? LESSON 3.2 WORKBOOK What is fast and slow metabolism? In the last lesson we saw data showing that the extent of obesity in the United States has risen dramatically, and we evaluated how obesity is measure

More information

Diabetes is usually a lifelong (chronic) disease in which there are high levels of sugar in the blood.

Diabetes is usually a lifelong (chronic) disease in which there are high levels of sugar in the blood. 1 of 15 12/30/2012 10:52 PM PubMed Health. A service of the National Library of Medicine, National Institutes of Health. A.D.A.M. Medical Encyclopedia. Atlanta (GA): A.D.A.M.; 2011. Diabetes Last reviewed:

More information

LESSON 2.4 WORKBOOK. Part two: Glucose homeostasis in the blood Un-Storing energy

LESSON 2.4 WORKBOOK. Part two: Glucose homeostasis in the blood Un-Storing energy DEFINITIONS OF TERMS Fasting A state of abstinence from all food or drinks that provide calories. For a complete list of defined terms, see the Glossary. LESSON 2.4 WORKBOOK Part two: Glucose homeostasis

More information

What is Diabetes Mellitus?

What is Diabetes Mellitus? Normal Glucose Metabolism What is Diabetes Mellitus? When the amount of glucose in the blood increases, After a meal, it triggers the release of the hormone insulin from the pancreas. Insulin stimulates

More information

QUESTIONS ANSWERED BY

QUESTIONS ANSWERED BY Module 21 QUESTIONS ANSWERED BY GARY TAUBES 2012, 2015 Integrative Nutrition, Inc. 2 Q What, if any, of the traditional lipid profile biomarkers should be considered indicative of heart disease or inflammation?

More information

Diabetes AN OVERVIEW. Diabetes is a disease in which the body is no longer

Diabetes AN OVERVIEW. Diabetes is a disease in which the body is no longer AN OVERVIEW Diabetes As you prepare to leave our center, we want to be sure you have the knowledge and skills to monitor and manage your own health conditions. You are the most important person on your

More information

CoreModels Glucose-Insulin Model A CORE LEARNING GOALS ACTIVITY FOR SCIENCE AND MATHEMATICS

CoreModels Glucose-Insulin Model A CORE LEARNING GOALS ACTIVITY FOR SCIENCE AND MATHEMATICS CoreModels Glucose-Insulin Model A CORE LEARNING GOALS ACTIVITY FOR SCIENCE AND MATHEMATICS Summary Students use two prebuilt STELLA models to investigate the relationship between the amount of glucose

More information

EB Education Revision Guide. How to work with Homeostasis: Part 2 Blood Glucose Regulation

EB Education Revision Guide. How to work with Homeostasis: Part 2 Blood Glucose Regulation EB Education Revision Guide How to work with Homeostasis: Part 2 Blood Glucose Regulation Blood Glucose Regulation a) Why your body regulates glucose levels What you need to know about Homeostasis: Part

More information

Standards of Care in Diabetes What's New? Veronica Brady, FNP-BC, PhD, BC-ADM,CDE Karmella Thomas, RD, LD,CDE

Standards of Care in Diabetes What's New? Veronica Brady, FNP-BC, PhD, BC-ADM,CDE Karmella Thomas, RD, LD,CDE Standards of Care in Diabetes 2016-- What's New? Veronica Brady, FNP-BC, PhD, BC-ADM,CDE Karmella Thomas, RD, LD,CDE Terminology No longer using the term diabetic. Diabetes does not define people. People

More information

AGENDA for 10/31/13 AGENDA: HOMEWORK: Due end of period. Due Fri, OBJECTIVES:

AGENDA for 10/31/13 AGENDA: HOMEWORK: Due end of period. Due Fri, OBJECTIVES: AGENDA for 10/31/13 AGENDA: 1. 2.1.1: Diagnosing Diabetes Part 2 Glucose Tolerance Testing Part 3 Insulin Level Testing OBJECTIVES: 1. Make an initial diagnosis of diabetes and characterize the disease

More information

LESSON 3.3 WORKBOOK. How do we decide when and how much to eat?

LESSON 3.3 WORKBOOK. How do we decide when and how much to eat? Appetite The psychological desire to eat, driven by feelings of pleasure from the brain. Hunger The biological or physiological need to eat, caused by a release of hormones from the digestive tract. LESSON

More information

Glucoregulation 1 of 27 Boardworks Ltd 2012

Glucoregulation 1 of 27 Boardworks Ltd 2012 Glucoregulation 1 of 27 Boardworks Ltd 2012 2 of 27 Boardworks Ltd 2012 Glucose 3 of 27 Boardworks Ltd 2012 Glucose is a type of sugar. It is the basic fuel for aerobic respiration, which provides the

More information

Case- history. Lab results

Case- history. Lab results Neda Rasouli, M.D. Associate Professor of Medicine Division of Endocrinology, UC Denver VA_ Eastern Colorado Health Care System Case- history 46 y/o AA male with BMI 37 presented in Oct 2001 with polyuria,

More information

Systematically Assessing the Promise of Type 2 Diabetes Remission

Systematically Assessing the Promise of Type 2 Diabetes Remission Systematically Assessing the Promise of Type 2 Diabetes Remission Is this the Next Frontier of Diabetes Care? Hertzel C. Gerstein MD MSc FRCPC McMaster University & Population Health Research Institute

More information

Take Charge Feel Positive About Nutrition. Marion J. Franz, MS, RD, CDE

Take Charge Feel Positive About Nutrition. Marion J. Franz, MS, RD, CDE Take Charge Feel Positive About Nutrition Marion J. Franz, MS, RD, CDE Questions What questions do you have? What s important? What s controversial? How important is weight loss? What about physical activity?

More information

Diabetes- A Silent Killer

Diabetes- A Silent Killer Diabetes- A Silent Killer What is Diabetes? Diabetes is a metabolic disorder in which the body fails to utilize the ingested glucose properly. This is due to lack of the hormone, Insulin or because the

More information

Diabetes Mellitus in the Pediatric Patient

Diabetes Mellitus in the Pediatric Patient Diabetes Mellitus in the Pediatric Patient William Bryant, M.D. Chief of Section Pediatric Endocrinology Children s Hospital at Scott & White Texas A&M University Temple, Texas Disclosures None Definitions

More information

DIABETES OVERVIEW WHAT IS DIABETES?

DIABETES OVERVIEW WHAT IS DIABETES? DIABETES OVERVIEW WHAT IS DIABETES? Diabetes is a disorder in which your body does not make insulin, not enough insulin, and/or your insulin does not work properly. Because the insulin is not working correctly,

More information

Station Neurons and synapses

Station Neurons and synapses Station 1 6.5 Neurons and synapses Label the neuron below: What is that neuron part? 1. Picks up message from neighboring neurons 2. Cells that cover axon and make myelin sheath 3. Releases neurotransmitter

More information

High-fat Diet Aggravates Islet Beta-cell Toxicity in Mice Treated with Clozapine

High-fat Diet Aggravates Islet Beta-cell Toxicity in Mice Treated with Clozapine Original Article 318 High-fat Diet Aggravates Islet Beta-cell Toxicity in Mice Treated with Clozapine Chung-Huei Huang, MD; Shin-Huei Fu 1 ; Samuel Hsu, MD; Yu-Yao Huang, MD, PhD; Szu-Tah Chen, MD, PhD;

More information

Metabolic Syndrome: What s so big about BIG?

Metabolic Syndrome: What s so big about BIG? Tuesday, 10:00 11:30, A2 Objectives: Notes: Metabolic Syndrome: What s so big about BIG? Patrice Conrad pbconrad1@att.net 1. Identify advances in clinical assessment and management of selected healthcare

More information

Helpful Hints for Taking Care of Your Diabetes. Farahnaz Joarder, MD and Don Kain, MA, RD,CDE Harold Schnitzer Diabetes Health Center

Helpful Hints for Taking Care of Your Diabetes. Farahnaz Joarder, MD and Don Kain, MA, RD,CDE Harold Schnitzer Diabetes Health Center Helpful Hints for Taking Care of Your Diabetes Farahnaz Joarder, MD and Don Kain, MA, RD,CDE Harold Schnitzer Diabetes Health Center Objectives How big of a problem is diabetes? What is diabetes? How is

More information

Type 2 DM in Adolescents: Use of GLP-1 RA. Objectives. Scope of Problem: Obesity. Background. Pathophysiology of T2DM

Type 2 DM in Adolescents: Use of GLP-1 RA. Objectives. Scope of Problem: Obesity. Background. Pathophysiology of T2DM Type 2 DM in Adolescents: Use of GLP-1 RA Objectives Identify patients in the pediatric population with T2DM that would potentially benefit from the use of GLP-1 RA Discuss changes in glycemic outcomes

More information

Counting the Carbs, Fat and Protein in Type 1 Diabetes Translating the Research into Clinical Practice

Counting the Carbs, Fat and Protein in Type 1 Diabetes Translating the Research into Clinical Practice Welcome to Allied Health Telehealth Virtual Education Counting the Carbs, Fats and Protein in Type 1 Diabetes Translating the Research into Clinical Practice Dr Carmel Smart, PhD Senior Specialist Paediatric

More information

Diabetes: Definition Pathophysiology Treatment Goals. By Scott Magee, MD, FACE

Diabetes: Definition Pathophysiology Treatment Goals. By Scott Magee, MD, FACE Diabetes: Definition Pathophysiology Treatment Goals By Scott Magee, MD, FACE Disclosures No disclosures to report Definition of Diabetes Mellitus Diabetes Mellitus comprises a group of disorders characterized

More information

Hypoglycemia in congenital hyperinsulinism

Hypoglycemia in congenital hyperinsulinism How a normal body works: Our body is constantly at work. Our cells need a source of energy, and this source of energy is called glucose. The process is quite simple; think of it like an assembly line.

More information

Type 1 Diabetes - Pediatrics

Type 1 Diabetes - Pediatrics Type 1 Diabetes - Pediatrics Introduction Type 1 diabetes prevents the body from removing sugar from the blood stream normally. Diabetes can lead to serious health problems if it is not treated. Currently

More information

Diabesity. Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs

Diabesity. Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs Diabesity Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs Abdominal obesity Low HDL, high LDL, and high triglycerides HTN High blood glucose (F>100l,

More information

History of Investigation

History of Investigation Acini - Pancreatic juice (1º) (2º) Secretions- neuronal and hormonal mechanisms 1) Secretin - bicarbonate rich 2) Cholecystokinin - enzyme rich Islets of Langerhans (contain 4 cell types) Alpha cells (α)-

More information

ENERGY FROM INGESTED NUTREINTS MAY BE USED IMMEDIATELY OR STORED

ENERGY FROM INGESTED NUTREINTS MAY BE USED IMMEDIATELY OR STORED QUIZ/TEST REVIEW NOTES SECTION 1 SHORT TERM METABOLISM [METABOLISM] Learning Objectives: Identify primary energy stores of the body Differentiate the metabolic processes of the fed and fasted states Explain

More information

Am I at Risk for Type 2 Diabetes?

Am I at Risk for Type 2 Diabetes? Am I at Risk for Type Diabetes? Taking Steps to Lower Your Risk of Getting Diabetes On this page: What is type diabetes? Can type diabetes be prevented? What are the signs and symptoms of type diabetes?

More information

Pathogenesis of Diabetes Mellitus

Pathogenesis of Diabetes Mellitus Pathogenesis of Diabetes Mellitus Young-Bum Kim, Ph.D. Associate Professor of Medicine Harvard Medical School Definition of Diabetes Mellitus a group of metabolic diseases characterized by hyperglycemia

More information

28 Regulation of Fasting and Post-

28 Regulation of Fasting and Post- 28 Regulation of Fasting and Post- Prandial Glucose Metabolism Keywords: Type 2 Diabetes, endogenous glucose production, splanchnic glucose uptake, gluconeo-genesis, glycogenolysis, glucose effectiveness.

More information

Diabetes Pathophysiology and Treatment Strategies

Diabetes Pathophysiology and Treatment Strategies Lehigh Valley Health Network LVHN Scholarly Works Department of Family Medicine Diabetes Pathophysiology and Treatment Strategies Beth Careyva MD Lehigh Valley Health Network, beth_a.careyva@lvhn.org Follow

More information

Christine Pelkman, PhD

Christine Pelkman, PhD Christine Pelkman, PhD Dr. Pelkman is a graduate faculty member in Nutrition, and Director of the Nutrition and Health Research Laboratory at the University of Buffalo. She completed her doctoral and postdoctoral

More information

Type 1 Diabetes TrialNet Long-term Investigative Follow-up in TrialNet (LIFT)

Type 1 Diabetes TrialNet Long-term Investigative Follow-up in TrialNet (LIFT) 1 Type 1 Diabetes TrialNet Long-term Investigative Follow-up in TrialNet (LIFT) Type 1 Diabetes TrialNet Researchers in this study are part of a larger group called Type 1 Diabetes TrialNet. TrialNet is

More information

DEVELOPMENT OF NEW ANIMAL MODELS FOR TYPE 2 DIABETES MELLITUS AND PHARMACOLOGICAL SCREENING

DEVELOPMENT OF NEW ANIMAL MODELS FOR TYPE 2 DIABETES MELLITUS AND PHARMACOLOGICAL SCREENING 2) LITERATURE REVIEW 1. Srinivasan et al., (2005) developed a new rat model that replicates the natural history and metabolic characteristics of human type 2 diabetes and is also suitable for pharmacological

More information

Prediabetes: Metformin vs. Lifestyle Intervention Tannaz Moin, MD, MBA, MSHS

Prediabetes: Metformin vs. Lifestyle Intervention Tannaz Moin, MD, MBA, MSHS Prediabetes: Metformin vs. Lifestyle Intervention Tannaz Moin, MD, MBA, MSHS Assistant Professor, David Geffen School of Medicine at UCLA Division of Endocrinology, Diabetes and Metabolism HSR&D Center

More information

INJECTABLE THERAPIES IN DIABETES. Barbara Ann McKee Diabetes Specialist Nurse

INJECTABLE THERAPIES IN DIABETES. Barbara Ann McKee Diabetes Specialist Nurse INJECTABLE THERAPIES IN DIABETES Barbara Ann McKee Diabetes Specialist Nurse 1 Aims of the session Describe the different injectable agents for diabetes and when they would be used. Describe some common

More information

Cordoba 01/02/2008. Slides Professor Pierre LEFEBVRE

Cordoba 01/02/2008. Slides Professor Pierre LEFEBVRE Cordoba 01/02/2008 Slides Professor Pierre LEFEBVRE Clinical Research in Type 2 Diabetes : Current Status and Future Approaches Pierre Lefèbvre* University of Liège Belgium Granada, Spain, February 2008

More information

Definition of diabetes mellitus

Definition of diabetes mellitus Diabetes mellitus II - III First and second type of diabetes mellitus Lecture from pathological physiology Oliver Rácz, 2011-2018 Definition of diabetes mellitus Diabetes mellitus is a group of metabolic

More information

METABOLISM CATABOLIC Carbohydrates Lipids Proteins

METABOLISM CATABOLIC Carbohydrates Lipids Proteins Index: - Overview: Catabolism and Anabolism. Few concepts:, NADPH. - Overview: Metabolism glucose, fatty acids and amino acids. - Table summary: Principal anabolic and catabolic pathways, and their main

More information

Treating Type 2 Diabetes by Treating Obesity. Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition

Treating Type 2 Diabetes by Treating Obesity. Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition Treating Type 2 Diabetes by Treating Obesity Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition 2 Center Stage Obesity is currently an epidemic in the United States, with

More information

associated with serious complications, but reduce occurrences with preventive measures

associated with serious complications, but reduce occurrences with preventive measures Wk 9. Management of Clients with Diabetes Mellitus 1. Diabetes Mellitus body s inability to metabolize carbohydrates, fats, proteins hyperglycemia associated with serious complications, but reduce occurrences

More information

Endocrine System. Regulating Blood Sugar. Thursday, December 14, 17

Endocrine System. Regulating Blood Sugar. Thursday, December 14, 17 Endocrine System Regulating Blood Sugar Stress results in nervous and hormonal responses. The adrenal glands are located above each kidney. Involved in stress response. Stress Upsets Homeostasis Stress

More information

Diabetes Mellitus. Raja Nursing Instructor. Acknowledgement: Badil 09/03/2016

Diabetes Mellitus. Raja Nursing Instructor. Acknowledgement: Badil 09/03/2016 Diabetes Mellitus Raja Nursing Instructor 09/03/2016 Acknowledgement: Badil Objective: Define Diabetes Mellitus (DM) & types of DM. Understand the pathophysiology of Type-I & II DM. List the clinical features

More information

The effect of food on triggering type II diabetes: modeling a CBD Pancreas

The effect of food on triggering type II diabetes: modeling a CBD Pancreas The effect of food on triggering type II diabetes: modeling a CBD Pancreas Mohamed Raef Smaoui School of Computer Science, McGill University, Montreal, QC, Canada Abstract Type II diabetes affects around

More information

18. PANCREATIC FUNCTION AND METABOLISM. Pancreatic secretions ISLETS OF LANGERHANS. Insulin

18. PANCREATIC FUNCTION AND METABOLISM. Pancreatic secretions ISLETS OF LANGERHANS. Insulin 18. PANCREATIC FUNCTION AND METABOLISM ISLETS OF LANGERHANS Some pancreatic functions have already been discussed in the digestion section. In this one, the emphasis will be placed on the endocrine function

More information

Nestlé Purina PetCare Company

Nestlé Purina PetCare Company Feline Fantasies: Feeding the carnivore Nestlé Purina PetCare Company D. P. Laflamme DVM, PhD DACVN Cats are Carnivores Carnivores are flesh eaters Carnivores are NOT meat eaters What is a Natural Diet?

More information

The Physiology of Weight Regulation: Implications for Effective Clinical Care

The Physiology of Weight Regulation: Implications for Effective Clinical Care Roundtable on Obesity Solutions The Physiology of Weight Regulation: Implications for Effective Clinical Care Lee M. Kaplan, MD, PhD Obesity, Metabolism & Nutrition Institute Massachusetts General Hospital

More information

What we know about energy balance

What we know about energy balance What we know about energy balance New understanding on how and why we gain and lose weight Presented by A/Professor Amanda Salis The Boden Institute of Obesity, Nutrition, Exercise & Eating Disorders The

More information

Associations among Body Mass Index, Insulin Resistance, and Pancreatic ß-Cell Function in Korean Patients with New- Onset Type 2 Diabetes

Associations among Body Mass Index, Insulin Resistance, and Pancreatic ß-Cell Function in Korean Patients with New- Onset Type 2 Diabetes ORIGINAL ARTICLE korean j intern med 2012;27:66-71 pissn 1226-3303 eissn 2005-6648 Associations among Body Mass Index, Insulin Resistance, and Pancreatic ß-Cell Function in Korean Patients with New- Onset

More information

1. What is Type 2 Diabetes Mellitus? Crucial Role of Maladaptive Changes in Beta Cell and Adipocyte Biology

1. What is Type 2 Diabetes Mellitus? Crucial Role of Maladaptive Changes in Beta Cell and Adipocyte Biology 1. What is Type 2 Diabetes Mellitus? Crucial Role of Maladaptive Changes in Beta Cell and Adipocyte Biology Jack L. Leahy, MD Richard E. Pratley, MD In the United States, 11.7% of males and 10.2% of females

More information

Chapter 4 Reading Guide

Chapter 4 Reading Guide Chapter 4 Reading Guide 1. How many covalent bonds does carbon (C) form? 2. What is the chemical formula for glucose? 3. List the major dietary monosaccharides and disaccharides. What are the components

More information

How low should we go?

How low should we go? How low should we go? Feedback from DiRECT: using low calorie diets with Type 2 Diabetes Alison Barnes Research Associate (Newcastle University) Diabetes Dietitian (Newcastle Hospitals NHS Trust) Diabetes

More information

Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes

Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes 666 Diabetes Care Volume 37, March 2014 CLIN CARE/EDUCATION/NUTRITION/PSYCHOSOCIAL Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes Gayatri Sarkar, 1 May Alattar,

More information

Diagnosis of Diabetes National Diabetes Information Clearinghouse

Diagnosis of Diabetes National Diabetes Information Clearinghouse Diagnosis of Diabetes National Diabetes Information Clearinghouse National Institute of Diabetes and Digestive and Kidney Diseases NATIONAL INSTITUTES OF HEALTH U.S. Department of Health and Human Services

More information

Tutorial ADAPT Case study 1. Data sampling / error model. Yared Paalvast Yvonne Rozendaal

Tutorial ADAPT Case study 1. Data sampling / error model. Yared Paalvast Yvonne Rozendaal Tutorial ADAPT 13.15 17.00 Yared Paalvast (t.paalvast@umcg.nl) Yvonne Rozendaal (y.j.w.rozendaal@tue.nl) Case study 1. Data sampling / error model 1.1 Visualize raw data (dataset1a.mat) time data: t concentration

More information

Progression to Diabetes: Hyperinsulinemia and Beta Cell Fatigue. By James L. Holly, MD Your Life Your Health The Examiner March 16, 2017

Progression to Diabetes: Hyperinsulinemia and Beta Cell Fatigue. By James L. Holly, MD Your Life Your Health The Examiner March 16, 2017 Progression to Diabetes: Hyperinsulinemia and Beta Cell Fatigue By James L. Holly, MD Your Life Your Health The Examiner March 16, 2017 When the liver, muscles and fat cells do not respond as they should

More information

Finding Ways Around High Dose Insulin Requirements: U-500 Insulin, Weight Loss, and Future Therapies

Finding Ways Around High Dose Insulin Requirements: U-500 Insulin, Weight Loss, and Future Therapies Finding Ways Around High Dose Insulin Requirements: U-500 Insulin, Weight Loss, and Future Therapies Elaine K. Cochran, MSN, CRNP, BC-ADM National Institute of Diabetes and Digestive and Kidney Diseases

More information

Management of Type 2 Diabetes

Management of Type 2 Diabetes Management of Type 2 Diabetes Pathophysiology Insulin resistance and relative insulin deficiency/ defective secretion Not immune mediated No evidence of β cell destruction Increased risk with age, obesity

More information

Type 1 Diabetes TrialNet Long-Term Investigative Follow-Up in TrialNet (LIFT)

Type 1 Diabetes TrialNet Long-Term Investigative Follow-Up in TrialNet (LIFT) 1 Type 1 Diabetes TrialNet Long-Term Investigative Follow-Up in TrialNet (LIFT) Type 1 Diabetes TrialNet Researchers in this study are part of a larger group called Type 1 Diabetes TrialNet. TrialNet is

More information

What is diabetes? Community Health Education Lecture Series November 18, Cara L. Kilroy, ANP-BC

What is diabetes? Community Health Education Lecture Series November 18, Cara L. Kilroy, ANP-BC What is diabetes? Community Health Education Lecture Series November 18, 2014 Cara L. Kilroy, ANP-BC About Diabetes Total prevalence of diabetes Total: 25.8 million children and adults in the United States

More information

Diabetes: Everything You Want to Know. LCDR Bernadine John, RN, BSN, CDE

Diabetes: Everything You Want to Know. LCDR Bernadine John, RN, BSN, CDE Diabetes: Everything You Want to Know LCDR Bernadine John, RN, BSN, CDE I have no financial affiliation to disclose as a conflict of interest regarding this presentation. DM Standards of Care The IHS Division

More information

Diabetes: Staying Two Steps Ahead. The prevalence of diabetes is increasing. What causes Type 2 diabetes?

Diabetes: Staying Two Steps Ahead. The prevalence of diabetes is increasing. What causes Type 2 diabetes? Focus on CME at the University of University Manitoba of Manitoba : Staying Two Steps Ahead By Shagufta Khan, MD; and Liam J. Murphy, MD The prevalence of diabetes is increasing worldwide and will double

More information

The Role of Certified Diabetes Educators Helping to Smooth the Transition to Insulin: Overcoming Psychological Insulin Resistance

The Role of Certified Diabetes Educators Helping to Smooth the Transition to Insulin: Overcoming Psychological Insulin Resistance The Role of Certified Diabetes Educators Helping to Smooth the Transition to Insulin: Overcoming Psychological Insulin Resistance Beverly S. Adler, PhD, CDE Clinical Psychologist Certified Diabetes Educator

More information

For Asian individuals the BMI numbers are 27.5 and 25 respectively These values are from the NICE guidelines of 2014

For Asian individuals the BMI numbers are 27.5 and 25 respectively These values are from the NICE guidelines of 2014 Ken Cathcart DO FACE We need to define several things to start the talk Obesity is defined medically as a BMI of greater than 30 or a BMI >27 with co-morbidities such as hypertension, type 2 DM, dyslipidemia,

More information

Physical Activity and the Prevention of Type 2 Diabetes Mellitus How Much for How Long?

Physical Activity and the Prevention of Type 2 Diabetes Mellitus How Much for How Long? CURRENT OPINION Sports Med 2000 Mar; 29 (3): 147-151 0112-1642/00/0003-0147/$20.00/0 Adis International Limited. All rights reserved. Physical Activity and the Prevention of Type 2 Diabetes Mellitus How

More information

How Diabetes Works by Craig C. Freudenrich, Ph.D.

How Diabetes Works by Craig C. Freudenrich, Ph.D. How Diabetes Works by Craig C. Freudenrich, Ph.D. Odds are that you know someone with diabetes mellitus, possibly even someone who has to take insulin each day to manage the disease. Diabetes is a growing

More information

Living Well with Diabetes

Living Well with Diabetes Living Well with Diabetes What is diabetes? Diabetes Overview Diabetes is a disorder of the way the body uses food for growth and energy. Most of the food people eat is broken down into glucose, the form

More information